Showing 5,501 - 5,520 results of 47,671 for search '"reporter"', query time: 0.12s Refine Results
  1. 5501
  2. 5502
  3. 5503
  4. 5504
  5. 5505
  6. 5506
  7. 5507
  8. 5508

    Psychometric validation of the Cystic Fibrosis Impact Questionnaire (CF-IQ): A patient-reported outcome assessing impacts of cystic fibrosis. by Daniel Serrano, Alyssa Uzumcu, Maya Gerstein, Nicolai D Ayasse, Ella Engstrom, Frederick B Barnes, Charles Iaconangelo, Teja Thorat, Lisa J McGarry, Isabelle Sermet-Gaudelus

    Published 2025-01-01
    “…The Cystic Fibrosis (CF) Impact Questionnaire (CF-IQ) was qualitatively developed to assess the impact of CF in the context of treatment advancements and increased longevity. This study reports the CF-IQ validation. In this noninterventional validation study, people with CF completed the 40-item CF-IQ and validating patient-reported outcome measures (PROMs) via electronic diaries at enrollment (baseline) and at the 4-week follow-up. …”
    Get full text
    Article
  9. 5509
  10. 5510

    Risk of angioedema and thrombolytic therapy among stroke patients: An analysis of data from the FDA Adverse Event Reporting System database by Hunong Xiang, Yu Ma, Xiaochao Luo, Jian Guo, Minghong Yao, Yanmei Liu, Ke Deng, Xin Sun, Ling Li

    Published 2025-01-01
    “…We conducted a large-scale retrospective pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database. Stroke patients receiving thrombolytic therapy (i.e., alteplase or tenecteplase) were identified, and the associations with angioedema were explored using disproportionality analysis and time-to-onset analysis. …”
    Get full text
    Article
  11. 5511
  12. 5512

    Use of Condition-Specific Patient-Reported Outcome Measures in Clinical Trials among Patients with Wrist Osteoarthritis: A Systematic Review by Steven M. McPhail, Karl S. Bagraith, Mandy Schippers, Paula J. Wells, Anna Hatton

    Published 2012-01-01
    “…The most common patient-reported outcome was the disabilities of the arm, shoulder, and hand questionnaire (DASH). …”
    Get full text
    Article
  13. 5513

    Prenatal Counseling and Diagnosis of COX20 Gene-Related Mitochondrial Complex IV Deficiency: A Case Report and Literature Review by Su J, Zeng L, Chen H, Tong J, Chen Y, Huang L, Deng L, Huang Y

    Published 2025-01-01
    “…A thorough review of the existing literature revealed seven additional cases carrying the same mutations. Moreover, this report delineated the process of prenatal counseling and diagnostic testing that was undertaken for the subsequent pregnancy of the patient’s mother.Conclusion: The presence of ataxia, cognitive impairment, and peripheral neuropathy in children should prompt consideration of COX20-related mitochondrial disease. …”
    Get full text
    Article
  14. 5514
  15. 5515
  16. 5516

    Silent Neuroleptic Malignant Syndrome: A Case Report of Atypical Antipsychotic Induced Elevation of Creatinine Kinase and Altered Mental Status by Amber N. Edinoff, Hamza Mohammad-Amin, Amira S. Odisho

    Published 2022-08-01
    “…The first was in an adolescent who was titrated to a dose of risperidone 3mg/ day but the only abnormality was an increase in his CK levels. The next case report was in a 40-year-old female who was on risperidone 2.5mg /day for one year. …”
    Get full text
    Article
  17. 5517
  18. 5518

    Muscle power is associated with higher levels of walking capacity and self-reported gait performance and physical activity in individuals with cerebral palsy by Mattie E. Pontiff, Mattie E. Pontiff, Abhinandan Batra, Li Li, Noelle G. Moreau

    Published 2025-01-01
    “…Walking capacity was measured using the 10-m walk test fast (FS) and self-selected (SS) speeds and the 1-min walk test (1MWT). Self-reported performance and participation measures were the Activities Scale for Kids-performance (ASKp), Patient-Reported Outcomes Measurement Information System (PROMIS®), and the Gait Outcomes Assessment List (GOAL). …”
    Get full text
    Article
  19. 5519
  20. 5520